Cashu Markets
Cashu
Markets
NT

Neoleukin Therapeutics

NGNE
NASDAQHealth Care

Income Statement

Total Revenue$0
Gross Profit$0
Operating Income$-83.53M
EBITDA$-71.14M
EBIT$-75.13M
Pre-tax Income$-87.22M
Net Income$-75.14M

Balance Sheet

Cash Equivalent$116.44M
Total Debt$13.76M
Book Value$193.4M
Book Value Per Share14.41

Key Ratios

Return on Equity (ROE)-24.21%
Return on Assets (ROA)-22.38%
Return on Invested Capital (ROI)-24.20%
Net Profit Margin-8123.68%
Current Ratio20.84
Quick Ratio20.72
Long-Term Debt / Equity0.25
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

About Cashu MarketsContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...